Total Payments
$9,624
2024 Payments
$1,781
Companies
22
Transactions
321
Medicare Patients
4,067
Medicare Billing
$197,882
Payment Breakdown by Category
Food & Beverage$8,961 (93.1%)
Education$663.40 (6.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,961 | 313 | 93.1% |
| Education | $663.40 | 8 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,058 | 60 | $0 (2024) |
| ABBVIE INC. | $1,546 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $827.70 | 15 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $670.85 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $601.44 | 29 | $0 (2024) |
| Lilly USA, LLC | $600.82 | 15 | $0 (2024) |
| LEO Pharma Inc. | $527.90 | 23 | $0 (2023) |
| Incyte Corporation | $504.14 | 16 | $0 (2024) |
| GENZYME CORPORATION | $503.98 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $440.63 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,781 | 37 | ABBVIE INC. ($391.72) |
| 2023 | $3,853 | 141 | Amgen Inc. ($819.29) |
| 2022 | $3,164 | 107 | Amgen Inc. ($839.16) |
| 2021 | $826.78 | 36 | Amgen Inc. ($296.57) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $140.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.64 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.90 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $76.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $76.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $99.99 | General |
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.52 | General |
| Category: Immunology | ||||||
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $90.88 | General |
| Category: Immunology | ||||||
| 08/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $87.57 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Immunology | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.57 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 07/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $117.68 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,106 | 1,970 | $184,401 | $52,943 |
| 2022 | 13 | 1,017 | 1,845 | $176,006 | $52,326 |
| 2021 | 11 | 1,188 | 2,114 | $195,877 | $57,027 |
| 2020 | 12 | 756 | 1,142 | $114,616 | $35,587 |
Total Patients
4,067
Total Services
7,071
Medicare Billing
$197,882
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 455 | $68,215 | $19,841 | 29.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 212 | 267 | $29,370 | $8,069 | 27.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 84 | 94 | $17,390 | $5,073 | 29.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 97 | 102 | $20,400 | $5,008 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 55 | $10,450 | $4,123 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $13,575 | $3,747 | 27.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 169 | 851 | $12,765 | $3,261 | 25.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $6,936 | $2,448 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 34 | $3,740 | $1,052 | 28.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 13 | $1,560 | $321.20 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 270 | 355 | $53,215 | $16,796 | 31.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 190 | 231 | $25,410 | $6,948 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 117 | 117 | $21,177 | $5,585 | 26.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 87 | 93 | $18,600 | $4,960 | 26.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 73 | 81 | $14,985 | $4,793 | 32.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 147 | 819 | $12,285 | $3,160 | 25.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 14 | 14 | $7,000 | $2,629 | 37.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 16 | 23 | $5,704 | $2,055 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $5,130 | $1,776 | 34.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 15 | $4,335 | $1,499 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 34 | $3,740 | $1,057 | 28.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $2,625 | $605.83 | 23.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 15 | $1,800 | $460.91 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 237 | 289 | $43,315 | $14,252 | 32.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 185 | 185 | $33,485 | $10,186 | 30.4% |
About Douglas Rhoda, PAC
Douglas Rhoda, PAC is a Physician Assistant healthcare provider based in Millinocket, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760494603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Douglas Rhoda, PAC has received a total of $9,624 in payments from pharmaceutical and medical device companies, with $1,781 received in 2024. These payments were reported across 321 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,961).
As a Medicare-enrolled provider, Rhoda has provided services to 4,067 Medicare beneficiaries, totaling 7,071 services with total Medicare billing of $197,882. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Millinocket, ME
- Active Since 08/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760494603
Products in Payments
- Otezla (Drug) $1,906
- DUPIXENT (Biological) $1,092
- TREMFYA (Drug) $809.34
- SKYRIZI (Biological) $745.70
- RINVOQ (Biological) $659.39
- ADBRY (Biological) $527.90
- OPZELURA (Drug) $504.14
- Sotyktu (Drug) $476.44
- Cimzia (Drug) $308.30
- AMELUZ (Drug) $244.56
- ILUMYA (Biological) $212.70
- TALTZ (Drug) $208.30
- EUCRISA (Drug) $163.31
- Enbrel (Biological) $152.64
- VTAMA (Drug) $124.78
- OLUMIANT (Drug) $117.68
- SIMPONI ARIA (Biological) $87.30
- BLU-U (Medical Supply) $84.66
- Odomzo (Drug) $72.47
- HUMIRA (Biological) $64.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.